Ingredient profile
ACRYLAMIDE/ACRYLOYLDIMETHYLTAURATE
Raters disagreeCAS 79-06-1
At least one of our safety lists speaks to this ingredient.
Raters don't agree. Here's where each one stands
Safe
Greenlens Precautionary Screen
Independent
Caution
US NTP Report on Carcinogens
Government
Concern
Greenlens Ingredient Scan
Independent
Greenlens Tolerance Screen
Independent
Health Canada Ingredient Hotlist
Government
IARC Monographs
Government
EU Harmonised Classification (CLP Annex VI)
Government
Where each list lands
Funding shown- Concern
Greenlens Ingredient Scan
Independent
Listed in Annex II of the EU Cosmetics Regulation (ref 681) — prohibited as an ingredient in cosmetic products. (EU Cosmetics Regulation Annex II (prohibited))
- Safe
Greenlens Precautionary Screen
Independent
No listed hazard trait recognized for this ingredient.
- Concern
Greenlens Tolerance Screen
Also screened — not on these lists
- California Proposition 65
- ANSES Endocrine Disruptors
- EU Microplastics Restriction
Where regulators stand
Shown side by side, never combinedEach jurisdiction is reported on its own terms, from its own official lists. Where they disagree, that disagreement is the finding. Absence from a list is never a safety claim.
European Union
BannedProhibited as a cosmetic ingredient in this jurisdiction.
- European Commission · EU Cosmetics Regulation Annex II (prohibited)Listed in Annex II of the EU Cosmetics Regulation (ref 681) — prohibited as an ingredient in cosmetic products.
- ECHA (EU CLP Regulation) · EU CLP Regulation Annex VI, Table 3 (harmonised classification, ECHA export): Carc. 1B, Muta. 1B, Repr. 2, Skin Sens. 1Carries an EU harmonised classification (Carc. 1B, Muta. 1B, Repr. 2, Skin Sens. 1) — a definite (category 1A/1B) carcinogen, mutagen or reproductive toxicant under CLP Annex VI, index 616-003-00-0. A hazard classification, not proof of harm at the level used.
Canada
BannedProhibited as a cosmetic ingredient in this jurisdiction.
Notes
- EU-prohibited
- Health Canada Hotlist — prohibited
- NTP anticipated carcinogen
- IARC probable carcinogen (Group 2A)
